ANLON HEALTHCARE Q2 FY27 CONCALL: MAINTAINS ₹380–400 CR FY27 & ₹650–700 CR FY28 REVENUE GUIDANCE; TARGETS 25–27% SUSTAINABLE EBITDA MARGIN, ₹250 CR FUNDRAISE & 1,200 MTPA CAPACITY EXPANSION